Hyperoside ameliorates NAFLD in rats via remodeling gut microbiota and reprogramming serum metabolic networks
Hyperoside ameliorates NAFLD, which is associated with gut microbiota remodeling and modulation of host metabolic networks, supporting its potential as a multi-target therapeutic agent for NAFLD.
Authors
- Weiwei Zeng (ORCID: https://orcid.org/0000-0001-6776-7087)
- Yanyan Li (ORCID: https://orcid.org/0000-0002-0233-8975)
- Ya Wang (ORCID: https://orcid.org/0000-0002-3971-4997)
- Mingchun Huang
Institutions
- Dalian Medical University (CN)
- Second Affiliated Hospital of Chongqing Medical University (CN)
- Dongguan People’s Hospital (CN)
- First People's Hospital of Chongqing (CN)
- Chongqing Medical University (CN)
Publication Details
- Journal
- Frontiers in Nutrition
- Published
- 2026-01-12
- DOI
- https://doi.org/10.3389/fnut.2025.1741026
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00